Biodexa Pharmaceuticals (BDRX) Stock Chart & Stock Price History $1.07 -0.03 (-2.73%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.08 +0.00 (+0.47%) As of 06/13/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Biodexa Pharmaceuticals Stock Price Performance The Biodexa Pharmaceuticals (BDRX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 73.58%. In the past month, the stock has decreased 18.32%, reflecting recent market activity. As of the latest close, Biodexa Pharmaceuticals traded at $1.07 with a market cap of $39.10 million and volume of 163,859 shares. Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.96%1 Month Performance-18.32%3 Month Performance-43.68%Year-To-Date Performance-73.58% BDRX Stock Chart for Saturday, June, 14, 2025 BDRX Chart by TradingView Biodexa Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$1.10$1.07-2.73%$1.12$1.03163,859 shs$39.10 million06/12/2025$1.13$1.10-2.65%$1.13$1.09102,592 shs$40.20 million06/11/2025$1.14$1.13-0.88%$1.16$1.12176,232 shs$41.30 million06/10/2025$1.15$1.14-0.87%$1.18$1.12213,337 shs$41.66 million06/09/2025$1.15$1.15$1.15$1.12217,470 shs$42.03 million06/06/2025$1.15$1.15$1.18$1.11247,373 shs$42.03 million06/05/2025$1.16$1.15-0.86%$1.18$1.13129,431 shs$42.03 million06/04/2025$1.16$1.16$1.18$1.12153,727 shs$42.39 million06/03/2025$1.15$1.16+0.87%$1.18$1.12295,771 shs$42.39 million06/02/2025$1.08$1.15+6.65%$1.26$1.061.17 million shs$42.03 million Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$1.06$1.08+1.73%$1.09$1.05404,338 shs$39.41 million05/29/2025$1.05$1.06+0.95%$1.10$1.01376,534 shs$38.74 million05/28/2025$1.15$1.05-8.70%$1.18$1.03518,232 shs$38.37 million05/27/2025$1.15$1.15$1.22$1.142.28 million shs$42.03 million05/26/2025$1.15$1.15$1.24$1.121.27 million shs$42.03 million05/23/2025$1.39$1.15-17.27%$1.24$1.121.27 million shs$42.03 million05/22/2025$1.30$1.39+6.92%$1.93$1.3162.69 million shs$50.80 million05/21/2025$1.32$1.30-1.52%$1.31$1.2923,372 shs$47.51 million05/20/2025$1.29$1.32+2.33%$1.32$1.2562,653 shs$48.24 million05/19/2025$1.28$1.29+0.78%$1.29$1.2260,869 shs$47.14 million05/16/2025$1.30$1.28-1.54%$1.30$1.2244,980 shs$46.78 million05/15/2025$1.31$1.30-0.76%$1.32$1.2432,786 shs$47.51 million05/14/2025$1.29$1.31+1.55%$1.38$1.2677,603 shs$47.87 million05/13/2025$1.23$1.29+4.88%$1.30$1.2475,536 shs$47.14 million Related Companies INmune Bio Stock Chart AC Immune Stock Chart Puma Biotechnology Stock Chart Neoleukin Therapeutics Stock Chart SELLAS Life Sciences Group Stock Chart Janone Stock Chart LifeVantage Stock Chart Prime Medicine Stock Chart Alpha Cognition Stock Chart Aclaris Therapeutics Stock Chart Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BDRX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
